Market Closed -
Nasdaq
04:00:00 2024-04-16 pm EDT
5-day change
1st Jan Change
2.15
USD
+3.37%
-7.33%
-12.42%
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from S&P Global BMI Index
September 19, 2022 at 12:00 am EDT
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from S&P Global BMI Index
Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Mar. 13
KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc
Mar. 13
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Mar. 13
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 13
CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M
Mar. 13
MT
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024
Mar. 13
CI
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic
Mar. 11
CI
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin
Mar. 06
CI
Transcript : KORU Medical Systems, Inc. - Analyst/Investor Day
Dec. 05
Transcript : KORU Medical Systems, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Nov. 08
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Revenue $7M, vs. Street Est of $7.9M
Nov. 08
MT
KORU Medical Systems, Inc. Announces Development Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
Nov. 08
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 08
CI
Koru Medical Systems, Inc. Appoints Kenneth Miller as Chief Commercial Officer
Nov. 08
CI
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes
Nov. 07
CI
KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to its Board of Directors
23-10-04
CI
Lake Street Starts Repro Med Systems at Buy
23-09-07
MT
B. Riley Starts Repro Med Systems at Buy With $4.50 Price Target, Says Risk/Reward Becoming More Favorable
23-09-07
MT
Transcript : KORU Medical Systems, Inc., Q2 2023 Earnings Call, Aug 09, 2023
23-08-09
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q2 Revenue $6.9M, vs. Street Est of $7.2M
23-08-09
MT
KORU Medical Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-09
CI
KORU Medical Systems, Inc. Updates Revenue Guidance for the Full Year 2023
23-08-09
CI
KORU Medical Systems, Inc. Provides Revenue Guidance for the Full Year 2023
23-08-02
CI
KORU Medical Systems, Inc. Announces Chief Financial Officer Changes
23-08-02
CI
KORU Medical Systems, Inc. Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
23-07-27
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. It is focused on home and specialty infusion solutions. The Company's focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient's subcutaneous tissues can tolerate and what the system delivers.
More about the company
Last Close Price
2.08
USD
Average target price
3.375
USD
Spread / Average Target
+62.26%
Consensus
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
KORU MEDICAL SYSTEMS, INC. 
